The MOMA team is proud to share research published in Nature Structural & Molecular Biology. This paper marks a major advancement in understanding the Pol-theta mechanism and its role in DNA repair—further underscoring the strong recognition of MOMA’s efforts in the field. Congratulations to our team members who drove this work forward, and a special thank you to Dr. Gabriel Lander (Scripps) and Christopher Zerio (Vividion) for your collaboration. We look forward to continuing this important research! Read the paper and discover more: https://lnkd.in/ejMwJVzg
Sami Takriti
2mo
Love it. DDR biology is incredibly complex. Kudos to the MOMA Therapeutics team for making big strides with the Pol-theta program. Keep charging!
Bede Portz Ph.D.
2mo
It is so cool to see a biotech, also managing to bring compounds to the clinic, prioritizing publishing basic science. In this market, and with all the fears of global competition, this is really neat to see. Well done, MOMA.
Communications | Marketing | Public & Media Relations
2moCongratulations everyone!